Cargando…
Chemotherapy in Nonmetastatic Osteosarcoma: Recent Advances and Implications for Developing Countries
PURPOSE: Osteosarcoma (OS) is a relatively chemosensitive primary bone tumor, with the peak age of onset occurring in late childhood and early adolescence. The treatment paradigm of nonmetastatic OS has typically been multimodality therapy, including neoadjuvant and adjuvant chemotherapy with defini...
Autores principales: | Rastogi, Sameer, Aggarwal, Aditi, Tiwari, Akash, Sharma, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180788/ https://www.ncbi.nlm.nih.gov/pubmed/30241154 http://dx.doi.org/10.1200/JGO.2016.007336 |
Ejemplares similares
-
Organization of Chemotherapy and Systemic Therapy Services in India: The Devil Lies in the Details
por: Rastogi, Sameer, et al.
Publicado: (2016) -
The Surgical Treatment and Outcome of Nonmetastatic Extremity Osteosarcoma with Pathological Fractures
por: Deng, Zhi-Ping, et al.
Publicado: (2015) -
Health-Related Quality of Life and Survival Outcomes of Pediatric
Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different
Resources
por: Bishop, Michael W., et al.
Publicado: (2017) -
Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
por: Bhattacharyya, Tapesh, et al.
Publicado: (2018) -
Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!
por: Rastogi, Sameer, et al.
Publicado: (2019)